Use of [(18)F]-FDG PET to predict response to neoadjuvant trastuzumab and docetaxel in patients with HER2-positive breast cancer, and addition of bevacizumab to neoadjuvant trastuzumab and docetaxel in [(18)F]-FDG PET-predicted non-responders (AVATA
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Thomas Bachelot Philippe Bougnoux Gilles Paintaud Bruno Coudert |
| Publication date | October 30, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |